Amylyx Pharmaceuticals Inc (AMLX)
1.755
-0.02
(-1.40%)
USD |
NASDAQ |
Apr 26, 16:00
1.755
0.00 (0.00%)
After-Hours: 20:00
Amylyx Pharmaceuticals Price: 1.755 for April 26, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 25, 2024 | 1.87 | 1.91 | 1.76 | 1.78 | 2.467M |
Apr 24, 2024 | 1.97 | 1.99 | 1.87 | 1.88 | 1.742M |
Apr 23, 2024 | 1.97 | 2.02 | 1.94 | 1.95 | 1.471M |
Apr 22, 2024 | 1.90 | 2.025 | 1.90 | 1.98 | 1.556M |
Apr 19, 2024 | 1.98 | 2.02 | 1.85 | 1.87 | 2.504M |
Apr 18, 2024 | 2.01 | 2.030 | 1.955 | 1.98 | 1.034M |
Apr 17, 2024 | 2.04 | 2.08 | 1.99 | 2.00 | 1.734M |
Apr 16, 2024 | 2.07 | 2.07 | 1.98 | 2.01 | 2.158M |
Apr 15, 2024 | 2.10 | 2.14 | 1.99 | 2.07 | 3.707M |
Apr 12, 2024 | 2.28 | 2.29 | 2.07 | 2.10 | 2.825M |
Apr 11, 2024 | 2.45 | 2.56 | 2.25 | 2.29 | 3.735M |
Apr 10, 2024 | 2.60 | 2.65 | 2.45 | 2.46 | 3.170M |
Apr 09, 2024 | 2.67 | 2.82 | 2.62 | 2.67 | 1.958M |
Apr 08, 2024 | 2.65 | 2.87 | 2.61 | 2.69 | 2.225M |
Apr 05, 2024 | 2.61 | 2.67 | 2.53 | 2.62 | 1.578M |
Apr 04, 2024 | 2.69 | 2.86 | 2.54 | 2.61 | 2.829M |
Apr 03, 2024 | 2.58 | 2.73 | 2.55 | 2.63 | 1.700M |
Apr 02, 2024 | 2.70 | 2.705 | 2.52 | 2.62 | 2.899M |
Apr 01, 2024 | 2.84 | 2.89 | 2.705 | 2.71 | 2.625M |
Mar 28, 2024 | 2.86 | 2.98 | 2.83 | 2.84 | 1.878M |
Mar 27, 2024 | 2.76 | 2.95 | 2.72 | 2.88 | 3.251M |
Mar 26, 2024 | 2.76 | 2.786 | 2.68 | 2.74 | 1.691M |
Mar 25, 2024 | 2.74 | 2.82 | 2.67 | 2.71 | 2.197M |
Mar 22, 2024 | 2.89 | 2.92 | 2.72 | 2.74 | 1.916M |
Mar 21, 2024 | 3.03 | 3.03 | 2.85 | 2.87 | 1.919M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.755
Minimum
Apr 26 2024
40.93
Maximum
Jan 27 2023
22.21
Average
21.75
Median
Price Benchmarks
Cassava Sciences Inc | 22.33 |
iRhythm Technologies Inc | 111.75 |
Bristol-Myers Squibb Co | 44.86 |
Moderna Inc | 107.79 |
ACADIA Pharmaceuticals Inc | 16.72 |
Price Related Metrics
PE Ratio | 2.507 |
PS Ratio | 0.3229 |
Price to Book Value | 0.2745 |
Price to Free Cash Flow | 11.52 |
Earnings Yield | 39.89% |
Market Cap | 118.96M |
Operating PE Ratio | 3.169 |
Normalized PE Ratio | 2.507 |